Immunic (NASDAQ:IMUX) executives outlined their multiple sclerosis (MS) development strategy and commercial thinking for ...

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

‘Active’ man diagnosed with MS at 26 after falling over on lads’ holiday in Ibiza - George Mckinty noticed the first sign of multiple sclerosis while at the gym in August 2021 ...

A group from Brigham and Women's Hospital in Boston, MA, has used mathematical modeling of MRI intensity change over time to examine the processes that lead to white matter damage in multiple ...

In multiple sclerosis, or MS, your immune system attacks myelin, the fatty tissue that surrounds and protects nerve fibers. This causes scar tissue (sclerosis, also called plaque or lesions) to form ...

A man from South Wales who was diagnosed with MS when he was 26 after experiencing vision loss and falling over on a lads’ holiday in Ibiza said the disease has “devastated” his social life and caused ...

MS patients are about twice as likely to develop restless legs syndrome than those without the disease, according to a study in Spain.

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...

Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...

The singer shares how a new treatment for multiple sclerosis has helped him hit the road for the band's 30th anniversary tour ...